Drug application
SUNITINIB MALATE (SUNITINIB MALATE)
Drugs@FDA ANDA 218012 · FOSUN WANBANG
Key facts
| Drug name | SUNITINIB MALATE |
|---|---|
| Active ingredients | SUNITINIB MALATE |
| Application type | ANDA |
| Application number | 218012 |
| Company | FOSUN WANBANG |
| Dosage forms | CAPSULE, ORAL |
| Strength | EQ 12.5MG BASE |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Aug 21, 2023 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.